Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populations
Olaf Stüve(Southwestern Medical Center), Bertis B. Little(University of Louisville), Danni McMahan(Dallas VA Medical Center), Rick Weideman(Dallas VA Medical Center), David Jacob(Central Texas Veterans Health Care System)
Cited by 42
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
|Nature Medicine|2007|448
Treatment of neuromyelitis optica: Review and recommendations
|Multiple Sclerosis and Related Disorders|2012|263